✦ LIBER ✦

Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection

✍ Scribed by Robert A. de Man; Leonieke M.M. Wolters; Frederik Nevens; David Chua; Morris Sherman; Cing L. Lai; Adrian Gadano; Youngmee Lee; Fransesco Mazzotta; Neil Thomas; Deborah DeHertogh

Book ID: 111721595
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 100 KB
Volume: 34
Category: Article
ISSN: 0270-9139
DOI: 10.1053/jhep.2001.26815

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of alamifovir in pat

Safety and efficacy of alamifovir in patients with chronic hepatitis B virus infection

✍ Danny K.W. Soon; Stephen L. Lowe; Choo Hua Teng; Kwee Poo Yeo; James McGill; Ste 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

The efficacy and safety of entecavir in

The efficacy and safety of entecavir in patients with advanced schistosomiasis co-infected with hepatitis B virus

✍ Huang, Li-Hua; Qiu, Yuan-Wang; Hua, Hai-Yong; Niu, Xue-Hua; Wu, Peng-Fei; Wu, Ha 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 279 KB

Efficacy of Entecavir and Adefovir Combi

Efficacy of Entecavir and Adefovir Combination Therapy for Patients with Lamivudine- and Entecavir-Resistant Chronic Hepatitis B

✍ Jung Won Jeon; Hyun Phil Shin; Joung Il Lee; Kwang Ro Joo; Jae Myung Cha; Jae Ju 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 199 KB

Efficacy and safety of entecavir in lami

Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: Randomized controlled trial in Japanese patients

✍ Fumitaka Suzuki; Joji Toyoda; Yoshiaki Katano; Michio Sata; Mitsuhiko Moriyama; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

535 SAFETY AND EFFICACY OF ENTECAVIR IN

535 SAFETY AND EFFICACY OF ENTECAVIR IN PATIENTS RECEIVING LIVER TRANSPLANT DUE TO CHRONIC HEPATITIS B

✍ R. Perrillo; M. Buti Ferret; F. Durand; M. Charlton; A. Gadano; G. Cantisani; K. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Efficacy and safety of entecavir versus

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study

✍ Yun-Fan Liaw; Maria Raptopoulou-Gigi; Hugo Cheinquer; Shiv Kumar Sarin; Tawesak 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 2 views

A randomized, open-label comparative study of entecavir versus adefovir therapy was performed in subjects with chronic hepatitis B who had hepatic decompensation (Child-Turcotte-Pugh score ≥7). Adult subjects were randomized and treated (n = 191) with entecavir 1.0 mg or adefovir 10 mg daily for up